Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

1.310 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3
Open 1.310
Bid (Size) 1.310 (100)
Ask (Size) 1.400 (500)
Prev. Close 1.310
Today's Range 1.310 - 1.310
52wk Range 1.310 - 2.630
Shares Outstanding 78,986,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
From Innate Pharma SA
Via Business Wire

Performance

YTD
-28.0%
-28.0%
1 Month
-22.5%
-22.5%
3 Month
-27.6%
-27.6%
6 Month
-36.1%
-36.1%
1 Year
-32.8%
-32.8%

More News

Read More
News headline image
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Releases Its 2026 Financial Calendar
From Innate Pharma SA
Via Business Wire
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗
Via Stocktwits
News headline image
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Present at Jefferies Global Healthcare Conference
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
From Innate Pharma SA
Via Business Wire
News headline image
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
From Innate Pharma SA
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗
Via Benzinga
News headline image
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
Earnings Scheduled For September 17, 2025 ↗
Via Benzinga
News headline image
Innate Pharma Reports First Half 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
From Innate Pharma SA
Via Business Wire

Frequently Asked Questions

Is Innate Pharma S.A. - American Depositary Shares publicly traded?
Yes, Innate Pharma S.A. - American Depositary Shares is publicly traded.
What exchange does Innate Pharma S.A. - American Depositary Shares trade on?
Innate Pharma S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Innate Pharma S.A. - American Depositary Shares?
The ticker symbol for Innate Pharma S.A. - American Depositary Shares is IPHA on the Nasdaq Stock Market
What is the current price of Innate Pharma S.A. - American Depositary Shares?
The current price of Innate Pharma S.A. - American Depositary Shares is 1.310
When was Innate Pharma S.A. - American Depositary Shares last traded?
The last trade of Innate Pharma S.A. - American Depositary Shares was at 03/18/26 04:00 PM ET
What is the market capitalization of Innate Pharma S.A. - American Depositary Shares?
The market capitalization of Innate Pharma S.A. - American Depositary Shares is 103.47M
How many shares of Innate Pharma S.A. - American Depositary Shares are outstanding?
Innate Pharma S.A. - American Depositary Shares has 103M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.